| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +40% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +120% |
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,919.50 +120.20 (2.50%) | 22,495.76 | 30.6 | 5.35 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,571.00 +41.30 (1.63%) | 19,542.61 | 28.82 | 5.45 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,500.50 -144.50 (1.89%) | 18,770.50 | 110.66 | 21.51 | ||
Natco PharmaNATCOPHARM | ₹886.85 -11.50 (1.28%) | 15,887.94 | 13.88 | 1.72 |